[Retracted] Systematic Evaluation of Randomized Clinical Trials of Huangqin Tang in Combination with Mesalazine for Ulcerative Colitis
Table 2
GRADE summary of HQT in the UC randomized controlled trial.
Evaluation of evidence quality
Outcome
Number of studies
Study design
Risk of bias
Inconsistency
Indirectness
Imprecision
Quality (evidence)
Importance of outcome
Cure rate
5
RCT
Seriousa
Seriousb
Not serious
Not serious
Low
Critical
Total effective rate
5
RCT
Seriousa
Not serious
Not serious
Not serious
Low
Critical
Diarrhea
2
RCT
Seriousc
Seriousd
Not serious
Not seriousgh
Low
Important
Abdominal pain
2
RCT
Seriousb
Seriousd
Not serious
Not seriousgh
Low
Important
Hematochezia
2
RCT
Seriousb
Seriousd
Not serious
Seriousgh
Low
Important
Tenesmus
2
RCT
Seriousb
Seriousd
Not serious
Seriousgh
Low
Important
TNF-α
3
RCT
Seriouse
Seriousf
Not serious
Not serious
Low
Important
IL-10
3
RCT
Seriouse
Not serious
Not serious
Not serious
Low
Important
IL-6
2
RCT
Seriousc
Not serious
Not serious
Seriousgh
Low
Important
IgM
2
RCT
Seriousc
Not serious
Not serious
Seriousgh
Low
Not important
IgG
2
RCT
Seriousc
Not serious
Not serious
Seriousgh
Low
Not important
IgA
2
RCT
Seriousc
Not serious
Not serious
Seriousgh
Low
Not important
Safety
3
RCT
Seriouse
Not serious
Not serious
Not serious
Low
Important
aThree studies used the random number table method; it was unclear whether the blind method was used, and random conceals were not reported. bOne study used a significant effect description in which the requirements for clinical symptoms and colonoscopy observation met the cure criteria. cOne study used the random number table method; it was unclear whether the blind method was used, and random conceals were not reported. dThere are operational differences in the clinical symptom score rules. eTwo studies adopted the random number table method, but it was not clear whether the blind method was adopted. fThe experimental data units of one study differed from those of the other studies. gSmall sample size. hLow event rate.